1 Study Coverage
    1.1 Epilepsy Drug Product Introduction
    1.2 Market by Type
        1.2.1 Global Epilepsy Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 First Generation Drugs
        1.2.3 Second Generation Drugs
        1.2.4 Third Generation Drugs
    1.3 Market by Application
        1.3.1 Global Epilepsy Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Epilepsy Drug Sales Estimates and Forecasts 2017-2028
    2.2 Global Epilepsy Drug Revenue Estimates and Forecasts 2017-2028
    2.3 Global Epilepsy Drug Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Epilepsy Drug Sales by Region
        2.4.1 Global Epilepsy Drug Sales by Region (2017-2022)
        2.4.2 Global Sales Epilepsy Drug by Region (2023-2028)
    2.5 Global Epilepsy Drug Revenue by Region
        2.5.1 Global Epilepsy Drug Revenue by Region (2017-2022)
        2.5.2 Global Epilepsy Drug Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Epilepsy Drug Sales by Manufacturers
        3.1.1 Global Top Epilepsy Drug Manufacturers by Sales (2017-2022)
        3.1.2 Global Epilepsy Drug Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Epilepsy Drug in 2021
    3.2 Global Epilepsy Drug Revenue by Manufacturers
        3.2.1 Global Epilepsy Drug Revenue by Manufacturers (2017-2022)
        3.2.2 Global Epilepsy Drug Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Epilepsy Drug Revenue in 2021
    3.3 Global Epilepsy Drug Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Epilepsy Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Epilepsy Drug Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Epilepsy Drug Sales by Type
        4.1.1 Global Epilepsy Drug Historical Sales by Type (2017-2022)
        4.1.2 Global Epilepsy Drug Forecasted Sales by Type (2023-2028)
        4.1.3 Global Epilepsy Drug Sales Market Share by Type (2017-2028)
    4.2 Global Epilepsy Drug Revenue by Type
        4.2.1 Global Epilepsy Drug Historical Revenue by Type (2017-2022)
        4.2.2 Global Epilepsy Drug Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Epilepsy Drug Revenue Market Share by Type (2017-2028)
    4.3 Global Epilepsy Drug Price by Type
        4.3.1 Global Epilepsy Drug Price by Type (2017-2022)
        4.3.2 Global Epilepsy Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Epilepsy Drug Sales by Application
        5.1.1 Global Epilepsy Drug Historical Sales by Application (2017-2022)
        5.1.2 Global Epilepsy Drug Forecasted Sales by Application (2023-2028)
        5.1.3 Global Epilepsy Drug Sales Market Share by Application (2017-2028)
    5.2 Global Epilepsy Drug Revenue by Application
        5.2.1 Global Epilepsy Drug Historical Revenue by Application (2017-2022)
        5.2.2 Global Epilepsy Drug Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Epilepsy Drug Revenue Market Share by Application (2017-2028)
    5.3 Global Epilepsy Drug Price by Application
        5.3.1 Global Epilepsy Drug Price by Application (2017-2022)
        5.3.2 Global Epilepsy Drug Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Epilepsy Drug Market Size by Type
        6.1.1 North America Epilepsy Drug Sales by Type (2017-2028)
        6.1.2 North America Epilepsy Drug Revenue by Type (2017-2028)
    6.2 North America Epilepsy Drug Market Size by Application
        6.2.1 North America Epilepsy Drug Sales by Application (2017-2028)
        6.2.2 North America Epilepsy Drug Revenue by Application (2017-2028)
    6.3 North America Epilepsy Drug Market Size by Country
        6.3.1 North America Epilepsy Drug Sales by Country (2017-2028)
        6.3.2 North America Epilepsy Drug Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Epilepsy Drug Market Size by Type
        7.1.1 Europe Epilepsy Drug Sales by Type (2017-2028)
        7.1.2 Europe Epilepsy Drug Revenue by Type (2017-2028)
    7.2 Europe Epilepsy Drug Market Size by Application
        7.2.1 Europe Epilepsy Drug Sales by Application (2017-2028)
        7.2.2 Europe Epilepsy Drug Revenue by Application (2017-2028)
    7.3 Europe Epilepsy Drug Market Size by Country
        7.3.1 Europe Epilepsy Drug Sales by Country (2017-2028)
        7.3.2 Europe Epilepsy Drug Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Epilepsy Drug Market Size by Type
        8.1.1 Asia Pacific Epilepsy Drug Sales by Type (2017-2028)
        8.1.2 Asia Pacific Epilepsy Drug Revenue by Type (2017-2028)
    8.2 Asia Pacific Epilepsy Drug Market Size by Application
        8.2.1 Asia Pacific Epilepsy Drug Sales by Application (2017-2028)
        8.2.2 Asia Pacific Epilepsy Drug Revenue by Application (2017-2028)
    8.3 Asia Pacific Epilepsy Drug Market Size by Region
        8.3.1 Asia Pacific Epilepsy Drug Sales by Region (2017-2028)
        8.3.2 Asia Pacific Epilepsy Drug Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Epilepsy Drug Market Size by Type
        9.1.1 Latin America Epilepsy Drug Sales by Type (2017-2028)
        9.1.2 Latin America Epilepsy Drug Revenue by Type (2017-2028)
    9.2 Latin America Epilepsy Drug Market Size by Application
        9.2.1 Latin America Epilepsy Drug Sales by Application (2017-2028)
        9.2.2 Latin America Epilepsy Drug Revenue by Application (2017-2028)
    9.3 Latin America Epilepsy Drug Market Size by Country
        9.3.1 Latin America Epilepsy Drug Sales by Country (2017-2028)
        9.3.2 Latin America Epilepsy Drug Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Epilepsy Drug Market Size by Type
        10.1.1 Middle East and Africa Epilepsy Drug Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Epilepsy Drug Revenue by Type (2017-2028)
    10.2 Middle East and Africa Epilepsy Drug Market Size by Application
        10.2.1 Middle East and Africa Epilepsy Drug Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Epilepsy Drug Revenue by Application (2017-2028)
    10.3 Middle East and Africa Epilepsy Drug Market Size by Country
        10.3.1 Middle East and Africa Epilepsy Drug Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Epilepsy Drug Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Pfizer
        11.1.1 Pfizer Corporation Information
        11.1.2 Pfizer Overview
        11.1.3 Pfizer Epilepsy Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Pfizer Epilepsy Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Pfizer Recent Developments
    11.2 Eisai
        11.2.1 Eisai Corporation Information
        11.2.2 Eisai Overview
        11.2.3 Eisai Epilepsy Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Eisai Epilepsy Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Eisai Recent Developments
    11.3 Novartis
        11.3.1 Novartis Corporation Information
        11.3.2 Novartis Overview
        11.3.3 Novartis Epilepsy Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Novartis Epilepsy Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Novartis Recent Developments
    11.4 Sanofi
        11.4.1 Sanofi Corporation Information
        11.4.2 Sanofi Overview
        11.4.3 Sanofi Epilepsy Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Sanofi Epilepsy Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Sanofi Recent Developments
    11.5 Union Chimique Belge
        11.5.1 Union Chimique Belge Corporation Information
        11.5.2 Union Chimique Belge Overview
        11.5.3 Union Chimique Belge Epilepsy Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Union Chimique Belge Epilepsy Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Union Chimique Belge Recent Developments
    11.6 Abbott
        11.6.1 Abbott Corporation Information
        11.6.2 Abbott Overview
        11.6.3 Abbott Epilepsy Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Abbott Epilepsy Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Abbott Recent Developments
    11.7 GlaxoSmithKline
        11.7.1 GlaxoSmithKline Corporation Information
        11.7.2 GlaxoSmithKline Overview
        11.7.3 GlaxoSmithKline Epilepsy Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 GlaxoSmithKline Epilepsy Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 GlaxoSmithKline Recent Developments
    11.8 Sunovion Pharmaceuticals
        11.8.1 Sunovion Pharmaceuticals Corporation Information
        11.8.2 Sunovion Pharmaceuticals Overview
        11.8.3 Sunovion Pharmaceuticals Epilepsy Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Sunovion Pharmaceuticals Epilepsy Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Sunovion Pharmaceuticals Recent Developments
    11.9 Teva Pharmaceutical
        11.9.1 Teva Pharmaceutical Corporation Information
        11.9.2 Teva Pharmaceutical Overview
        11.9.3 Teva Pharmaceutical Epilepsy Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Teva Pharmaceutical Epilepsy Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Teva Pharmaceutical Recent Developments
    11.10 Johnson & Johnson
        11.10.1 Johnson & Johnson Corporation Information
        11.10.2 Johnson & Johnson Overview
        11.10.3 Johnson & Johnson Epilepsy Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Johnson & Johnson Epilepsy Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Johnson & Johnson Recent Developments
    11.11 Abbvie
        11.11.1 Abbvie Corporation Information
        11.11.2 Abbvie Overview
        11.11.3 Abbvie Epilepsy Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Abbvie Epilepsy Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Abbvie Recent Developments
    11.12 Janssen Pharmaceuticals
        11.12.1 Janssen Pharmaceuticals Corporation Information
        11.12.2 Janssen Pharmaceuticals Overview
        11.12.3 Janssen Pharmaceuticals Epilepsy Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Janssen Pharmaceuticals Epilepsy Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Janssen Pharmaceuticals Recent Developments
    11.13 Cephalon
        11.13.1 Cephalon Corporation Information
        11.13.2 Cephalon Overview
        11.13.3 Cephalon Epilepsy Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Cephalon Epilepsy Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Cephalon Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Epilepsy Drug Industry Chain Analysis
    12.2 Epilepsy Drug Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Epilepsy Drug Production Mode & Process
    12.4 Epilepsy Drug Sales and Marketing
        12.4.1 Epilepsy Drug Sales Channels
        12.4.2 Epilepsy Drug Distributors
    12.5 Epilepsy Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Epilepsy Drug Industry Trends
    13.2 Epilepsy Drug Market Drivers
    13.3 Epilepsy Drug Market Challenges
    13.4 Epilepsy Drug Market Restraints
14 Key Findings in The Global Epilepsy Drug Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Epilepsy Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of First Generation Drugs
    Table 3. Major Manufacturers of Second Generation Drugs
    Table 4. Major Manufacturers of Third Generation Drugs
    Table 5. Global Epilepsy Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Epilepsy Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Epilepsy Drug Sales by Region (2017-2022) & (MT)
    Table 8. Global Epilepsy Drug Sales Market Share by Region (2017-2022)
    Table 9. Global Epilepsy Drug Sales by Region (2023-2028) & (MT)
    Table 10. Global Epilepsy Drug Sales Market Share by Region (2023-2028)
    Table 11. Global Epilepsy Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Epilepsy Drug Revenue Market Share by Region (2017-2022)
    Table 13. Global Epilepsy Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Epilepsy Drug Revenue Market Share by Region (2023-2028)
    Table 15. Global Epilepsy Drug Sales by Manufacturers (2017-2022) & (MT)
    Table 16. Global Epilepsy Drug Sales Share by Manufacturers (2017-2022)
    Table 17. Global Epilepsy Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Epilepsy Drug Revenue Share by Manufacturers (2017-2022)
    Table 19. Epilepsy Drug Price by Manufacturers (2017-2022) &(USD/MT)
    Table 20. Global Epilepsy Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Epilepsy Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epilepsy Drug as of 2021)
    Table 22. Epilepsy Drug Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Epilepsy Drug Product Offered
    Table 24. Date of Manufacturers Enter into Epilepsy Drug Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Epilepsy Drug Sales by Type (2017-2022) & (MT)
    Table 27. Global Epilepsy Drug Sales by Type (2023-2028) & (MT)
    Table 28. Global Epilepsy Drug Sales Share by Type (2017-2022)
    Table 29. Global Epilepsy Drug Sales Share by Type (2023-2028)
    Table 30. Global Epilepsy Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Epilepsy Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Epilepsy Drug Revenue Share by Type (2017-2022)
    Table 33. Global Epilepsy Drug Revenue Share by Type (2023-2028)
    Table 34. Epilepsy Drug Price by Type (2017-2022) & (USD/MT)
    Table 35. Global Epilepsy Drug Price Forecast by Type (2023-2028) & (USD/MT)
    Table 36. Global Epilepsy Drug Sales by Application (2017-2022) & (MT)
    Table 37. Global Epilepsy Drug Sales by Application (2023-2028) & (MT)
    Table 38. Global Epilepsy Drug Sales Share by Application (2017-2022)
    Table 39. Global Epilepsy Drug Sales Share by Application (2023-2028)
    Table 40. Global Epilepsy Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Epilepsy Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Epilepsy Drug Revenue Share by Application (2017-2022)
    Table 43. Global Epilepsy Drug Revenue Share by Application (2023-2028)
    Table 44. Epilepsy Drug Price by Application (2017-2022) & (USD/MT)
    Table 45. Global Epilepsy Drug Price Forecast by Application (2023-2028) & (USD/MT)
    Table 46. North America Epilepsy Drug Sales by Type (2017-2022) & (MT)
    Table 47. North America Epilepsy Drug Sales by Type (2023-2028) & (MT)
    Table 48. North America Epilepsy Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Epilepsy Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Epilepsy Drug Sales by Application (2017-2022) & (MT)
    Table 51. North America Epilepsy Drug Sales by Application (2023-2028) & (MT)
    Table 52. North America Epilepsy Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Epilepsy Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Epilepsy Drug Sales by Country (2017-2022) & (MT)
    Table 55. North America Epilepsy Drug Sales by Country (2023-2028) & (MT)
    Table 56. North America Epilepsy Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Epilepsy Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Epilepsy Drug Sales by Type (2017-2022) & (MT)
    Table 59. Europe Epilepsy Drug Sales by Type (2023-2028) & (MT)
    Table 60. Europe Epilepsy Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Epilepsy Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Epilepsy Drug Sales by Application (2017-2022) & (MT)
    Table 63. Europe Epilepsy Drug Sales by Application (2023-2028) & (MT)
    Table 64. Europe Epilepsy Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Epilepsy Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Epilepsy Drug Sales by Country (2017-2022) & (MT)
    Table 67. Europe Epilepsy Drug Sales by Country (2023-2028) & (MT)
    Table 68. Europe Epilepsy Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Epilepsy Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Epilepsy Drug Sales by Type (2017-2022) & (MT)
    Table 71. Asia Pacific Epilepsy Drug Sales by Type (2023-2028) & (MT)
    Table 72. Asia Pacific Epilepsy Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Epilepsy Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Epilepsy Drug Sales by Application (2017-2022) & (MT)
    Table 75. Asia Pacific Epilepsy Drug Sales by Application (2023-2028) & (MT)
    Table 76. Asia Pacific Epilepsy Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Epilepsy Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Epilepsy Drug Sales by Region (2017-2022) & (MT)
    Table 79. Asia Pacific Epilepsy Drug Sales by Region (2023-2028) & (MT)
    Table 80. Asia Pacific Epilepsy Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Epilepsy Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Epilepsy Drug Sales by Type (2017-2022) & (MT)
    Table 83. Latin America Epilepsy Drug Sales by Type (2023-2028) & (MT)
    Table 84. Latin America Epilepsy Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Epilepsy Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Epilepsy Drug Sales by Application (2017-2022) & (MT)
    Table 87. Latin America Epilepsy Drug Sales by Application (2023-2028) & (MT)
    Table 88. Latin America Epilepsy Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Epilepsy Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Epilepsy Drug Sales by Country (2017-2022) & (MT)
    Table 91. Latin America Epilepsy Drug Sales by Country (2023-2028) & (MT)
    Table 92. Latin America Epilepsy Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Epilepsy Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Epilepsy Drug Sales by Type (2017-2022) & (MT)
    Table 95. Middle East and Africa Epilepsy Drug Sales by Type (2023-2028) & (MT)
    Table 96. Middle East and Africa Epilepsy Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Epilepsy Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Epilepsy Drug Sales by Application (2017-2022) & (MT)
    Table 99. Middle East and Africa Epilepsy Drug Sales by Application (2023-2028) & (MT)
    Table 100. Middle East and Africa Epilepsy Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Epilepsy Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Epilepsy Drug Sales by Country (2017-2022) & (MT)
    Table 103. Middle East and Africa Epilepsy Drug Sales by Country (2023-2028) & (MT)
    Table 104. Middle East and Africa Epilepsy Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Epilepsy Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Pfizer Corporation Information
    Table 107. Pfizer Description and Major Businesses
    Table 108. Pfizer Epilepsy Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 109. Pfizer Epilepsy Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Pfizer Recent Developments
    Table 111. Eisai Corporation Information
    Table 112. Eisai Description and Major Businesses
    Table 113. Eisai Epilepsy Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 114. Eisai Epilepsy Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Eisai Recent Developments
    Table 116. Novartis Corporation Information
    Table 117. Novartis Description and Major Businesses
    Table 118. Novartis Epilepsy Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 119. Novartis Epilepsy Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Novartis Recent Developments
    Table 121. Sanofi Corporation Information
    Table 122. Sanofi Description and Major Businesses
    Table 123. Sanofi Epilepsy Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 124. Sanofi Epilepsy Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Sanofi Recent Developments
    Table 126. Union Chimique Belge Corporation Information
    Table 127. Union Chimique Belge Description and Major Businesses
    Table 128. Union Chimique Belge Epilepsy Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 129. Union Chimique Belge Epilepsy Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Union Chimique Belge Recent Developments
    Table 131. Abbott Corporation Information
    Table 132. Abbott Description and Major Businesses
    Table 133. Abbott Epilepsy Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 134. Abbott Epilepsy Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Abbott Recent Developments
    Table 136. GlaxoSmithKline Corporation Information
    Table 137. GlaxoSmithKline Description and Major Businesses
    Table 138. GlaxoSmithKline Epilepsy Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 139. GlaxoSmithKline Epilepsy Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. GlaxoSmithKline Recent Developments
    Table 141. Sunovion Pharmaceuticals Corporation Information
    Table 142. Sunovion Pharmaceuticals Description and Major Businesses
    Table 143. Sunovion Pharmaceuticals Epilepsy Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 144. Sunovion Pharmaceuticals Epilepsy Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Sunovion Pharmaceuticals Recent Developments
    Table 146. Teva Pharmaceutical Corporation Information
    Table 147. Teva Pharmaceutical Description and Major Businesses
    Table 148. Teva Pharmaceutical Epilepsy Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 149. Teva Pharmaceutical Epilepsy Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. Teva Pharmaceutical Recent Developments
    Table 151. Johnson & Johnson Corporation Information
    Table 152. Johnson & Johnson Description and Major Businesses
    Table 153. Johnson & Johnson Epilepsy Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 154. Johnson & Johnson Epilepsy Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 155. Johnson & Johnson Recent Developments
    Table 156. Abbvie Corporation Information
    Table 157. Abbvie Description and Major Businesses
    Table 158. Abbvie Epilepsy Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 159. Abbvie Epilepsy Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 160. Abbvie Recent Developments
    Table 161. Janssen Pharmaceuticals Corporation Information
    Table 162. Janssen Pharmaceuticals Description and Major Businesses
    Table 163. Janssen Pharmaceuticals Epilepsy Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 164. Janssen Pharmaceuticals Epilepsy Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 165. Janssen Pharmaceuticals Recent Developments
    Table 166. Cephalon Corporation Information
    Table 167. Cephalon Description and Major Businesses
    Table 168. Cephalon Epilepsy Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 169. Cephalon Epilepsy Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 170. Cephalon Recent Developments
    Table 171. Key Raw Materials Lists
    Table 172. Raw Materials Key Suppliers Lists
    Table 173. Epilepsy Drug Distributors List
    Table 174. Epilepsy Drug Customers List
    Table 175. Epilepsy Drug Market Trends
    Table 176. Epilepsy Drug Market Drivers
    Table 177. Epilepsy Drug Market Challenges
    Table 178. Epilepsy Drug Market Restraints
    Table 179. Research Programs/Design for This Report
    Table 180. Key Data Information from Secondary Sources
    Table 181. Key Data Information from Primary Sources
List of Figures
    Figure 1. Epilepsy Drug Product Picture
    Figure 3. Global Epilepsy Drug Market Share by Type in 2021 & 2028
    Figure 3. First Generation Drugs Product Picture
    Figure 4. Second Generation Drugs Product Picture
    Figure 5. Third Generation Drugs Product Picture
    Figure 6. Global Epilepsy Drug Market Share by Application in 2021 & 2028
    Figure 7. Hospital
    Figure 8. Clinic
    Figure 9. Others
    Figure 10. Epilepsy Drug Report Years Considered
    Figure 11. Global Epilepsy Drug Sales 2017-2028 (MT)
    Figure 12. Global Epilepsy Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Epilepsy Drug Revenue 2017-2028 (US$ Million)
    Figure 14. Global Epilepsy Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 15. Global Epilepsy Drug Sales Market Share by Region (2017-2022)
    Figure 16. Global Epilepsy Drug Sales Market Share by Region (2023-2028)
    Figure 17. North America Epilepsy Drug Sales YoY (2017-2028) & (MT)
    Figure 18. North America Epilepsy Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Europe Epilepsy Drug Sales YoY (2017-2028) & (MT)
    Figure 20. Europe Epilepsy Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Asia-Pacific Epilepsy Drug Sales YoY (2017-2028) & (MT)
    Figure 22. Asia-Pacific Epilepsy Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Latin America Epilepsy Drug Sales YoY (2017-2028) & (MT)
    Figure 24. Latin America Epilepsy Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Middle East & Africa Epilepsy Drug Sales YoY (2017-2028) & (MT)
    Figure 26. Middle East & Africa Epilepsy Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. The Epilepsy Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 28. The Top 5 and 10 Largest Manufacturers of Epilepsy Drug in the World: Market Share by Epilepsy Drug Revenue in 2021
    Figure 29. Global Epilepsy Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 30. Global Epilepsy Drug Sales Market Share by Type (2017-2028)
    Figure 31. Global Epilepsy Drug Revenue Market Share by Type (2017-2028)
    Figure 32. Global Epilepsy Drug Sales Market Share by Application (2017-2028)
    Figure 33. Global Epilepsy Drug Revenue Market Share by Application (2017-2028)
    Figure 34. North America Epilepsy Drug Sales Market Share by Type (2017-2028)
    Figure 35. North America Epilepsy Drug Revenue Market Share by Type (2017-2028)
    Figure 36. North America Epilepsy Drug Sales Market Share by Application (2017-2028)
    Figure 37. North America Epilepsy Drug Revenue Market Share by Application (2017-2028)
    Figure 38. North America Epilepsy Drug Sales Share by Country (2017-2028)
    Figure 39. North America Epilepsy Drug Revenue Share by Country (2017-2028)
    Figure 40. U.S. Epilepsy Drug Revenue (2017-2028) & (US$ Million)
    Figure 41. Canada Epilepsy Drug Revenue (2017-2028) & (US$ Million)
    Figure 42. Europe Epilepsy Drug Sales Market Share by Type (2017-2028)
    Figure 43. Europe Epilepsy Drug Revenue Market Share by Type (2017-2028)
    Figure 44. Europe Epilepsy Drug Sales Market Share by Application (2017-2028)
    Figure 45. Europe Epilepsy Drug Revenue Market Share by Application (2017-2028)
    Figure 46. Europe Epilepsy Drug Sales Share by Country (2017-2028)
    Figure 47. Europe Epilepsy Drug Revenue Share by Country (2017-2028)
    Figure 48. Germany Epilepsy Drug Revenue (2017-2028) & (US$ Million)
    Figure 49. France Epilepsy Drug Revenue (2017-2028) & (US$ Million)
    Figure 50. U.K. Epilepsy Drug Revenue (2017-2028) & (US$ Million)
    Figure 51. Italy Epilepsy Drug Revenue (2017-2028) & (US$ Million)
    Figure 52. Russia Epilepsy Drug Revenue (2017-2028) & (US$ Million)
    Figure 53. Asia Pacific Epilepsy Drug Sales Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Epilepsy Drug Revenue Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Epilepsy Drug Sales Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Epilepsy Drug Revenue Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Epilepsy Drug Sales Share by Region (2017-2028)
    Figure 58. Asia Pacific Epilepsy Drug Revenue Share by Region (2017-2028)
    Figure 59. China Epilepsy Drug Revenue (2017-2028) & (US$ Million)
    Figure 60. Japan Epilepsy Drug Revenue (2017-2028) & (US$ Million)
    Figure 61. South Korea Epilepsy Drug Revenue (2017-2028) & (US$ Million)
    Figure 62. India Epilepsy Drug Revenue (2017-2028) & (US$ Million)
    Figure 63. Australia Epilepsy Drug Revenue (2017-2028) & (US$ Million)
    Figure 64. Taiwan Epilepsy Drug Revenue (2017-2028) & (US$ Million)
    Figure 65. Indonesia Epilepsy Drug Revenue (2017-2028) & (US$ Million)
    Figure 66. Thailand Epilepsy Drug Revenue (2017-2028) & (US$ Million)
    Figure 67. Malaysia Epilepsy Drug Revenue (2017-2028) & (US$ Million)
    Figure 68. Philippines Epilepsy Drug Revenue (2017-2028) & (US$ Million)
    Figure 69. Latin America Epilepsy Drug Sales Market Share by Type (2017-2028)
    Figure 70. Latin America Epilepsy Drug Revenue Market Share by Type (2017-2028)
    Figure 71. Latin America Epilepsy Drug Sales Market Share by Application (2017-2028)
    Figure 72. Latin America Epilepsy Drug Revenue Market Share by Application (2017-2028)
    Figure 73. Latin America Epilepsy Drug Sales Share by Country (2017-2028)
    Figure 74. Latin America Epilepsy Drug Revenue Share by Country (2017-2028)
    Figure 75. Mexico Epilepsy Drug Revenue (2017-2028) & (US$ Million)
    Figure 76. Brazil Epilepsy Drug Revenue (2017-2028) & (US$ Million)
    Figure 77. Argentina Epilepsy Drug Revenue (2017-2028) & (US$ Million)
    Figure 78. Middle East and Africa Epilepsy Drug Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Epilepsy Drug Revenue Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Epilepsy Drug Sales Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Epilepsy Drug Revenue Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Epilepsy Drug Sales Share by Country (2017-2028)
    Figure 83. Middle East and Africa Epilepsy Drug Revenue Share by Country (2017-2028)
    Figure 84. Turkey Epilepsy Drug Revenue (2017-2028) & (US$ Million)
    Figure 85. Saudi Arabia Epilepsy Drug Revenue (2017-2028) & (US$ Million)
    Figure 86. U.A.E Epilepsy Drug Revenue (2017-2028) & (US$ Million)
    Figure 87. Epilepsy Drug Value Chain
    Figure 88. Epilepsy Drug Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed